Alvotech and Lotte Biologics announce U.S.-based manufacturing agreement to increase global supply

ALVO•2026-10-06

Alvotech and Lotte Biologics agreed to manufacture multiple biosimilars at Lotte Biologics' Syracuse facility for global supply.

1. Manufacturing agreement

Alvotech and Lotte Biologics announced a U.S.-based manufacturing agreement to increase global supply. The companies will manufacture multiple biosimilars at Lotte Biologics' Syracuse facility.

Alvotech and Lotte Biologics announce U.S.-based manufacturing agreement to increase global supply

1. Manufacturing agreement

Related News

BlackRock cuts AT&S voting rights to 3.97% from 4.01%

Fair Isaac to cut about 15% of workforce

Hang Feng Technology Innovation may offer up to $200 million in securities

ProMIS Neurosciences files initial Form 3 for Chief Commercial Officer Ivana Rubino

Radiant Logistics buys Whitacre Logistics’ Dallas operations through Radiant Road & Rail